| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From ICGM-CHU Cochin,*
Laboratoire de Biochimie et
Biologie Moléculaire EA1501, Paris, France; the Department of
Medical and Molecular Genetics,
Indiana
University School of Medicine, and the Richard L. Roudebush Veterans
Affairs Medical Center,
Indianapolis,
Indiana; the Service de Dermatologie,§
Hôpital de l'Antiquaille, and the Laboratoire d'Anatomie
Pathologique,||
Hôpital Cardio-vasculaire Louis
Pradel, Lyon, France; the Service de
Cardiologie,¶ Centre Hospitalier
Général, Annecy, France; and the Service de Médecine
Interne,**
L'Hôtel Dieu de Paris,
Paris, France
Autosomal dominant hereditary amyloidosis with a unique cutaneous and cardiac presentation and death from heart failure by the sixth or seventh decade was found to be associated with a previously unreported point mutation (thymine to cytosine, nt 1389) in exon 4 of the apolipoprotein A1 (apoA1) gene. The predicted substitution of proline for leucine at amino acid position 90 was confirmed by structural analysis of amyloid protein isolated from cardiac deposits of amyloid. The subunit protein is composed exclusively of NH2-terminal fragments of the variant apoA1 with the longest ending at residue 94 in the wild-type sequence. Amyloid fibrils derived from four previously described apoA1 variants are composed of similar fragments with carboxyl-terminal heterogeneity, but contrary to those variants, which all carry one extra positive charge, the substitution Leu90Pro does not result in any charge modification. It is unlikely, therefore, that amyloid fibril formation is related to change of charge for a specific residue of the precursor protein. This is in agreement with studies on transthyretin amyloidosis in which no unifying factor such as change of charge for amino acid residues has been noted.
This article has been cited by other articles:
![]() |
M. Eriksson, S. Schonland, S. Yumlu, U. Hegenbart, H. von Hutten, Z. Gioeva, P. Lohse, J. Buttner, H. Schmidt, and C. Rocken Hereditary Apolipoprotein AI-Associated Amyloidosis in Surgical Pathology Specimens: Identification of Three Novel Mutations in the APOA1 Gene J. Mol. Diagn., May 1, 2009; 11(3): 257 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gillmore, H. J. Lachmann, D. Rowczenio, J. A. Gilbertson, C.-H. Zeng, Z.-H. Liu, L.-S. Li, A. Wechalekar, and P. N. Hawkins Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen A{alpha}-Chain Amyloidosis J. Am. Soc. Nephrol., February 1, 2009; 20(2): 444 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
H J Lachmann and P N Hawkins Amyloidosis and the lung Chronic Respiratory Disease, November 1, 2006; 3(4): 203 - 214. [Abstract] [PDF] |
||||
![]() |
G. Gregorini, C. Izzi, L. Obici, R. Tardanico, C. Rocken, B. F. Viola, M. Capistrano, S. Donadei, L. Biasi, T. Scalvini, et al. Renal Apolipoprotein A-I Amyloidosis: A Rare and Usually Ignored Cause of Hereditary Tubulointerstitial Nephritis J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3680 - 3686. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Korenaga, X. Fu, Y. Xing, T. Matsusita, K. Kuramoto, S. Syumiya, K. Hasegawa, H. Naiki, M. Ueno, T. Ishihara, et al. Tissue Distribution, Biochemical Properties, and Transmission of Mouse Type A AApoAII Amyloid Fibrils Am. J. Pathol., May 1, 2004; 164(5): 1597 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Andreola, V. Bellotti, S. Giorgetti, P. Mangione, L. Obici, M. Stoppini, J. Torres, E. Monzani, G. Merlini, and M. Sunde Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I J. Biol. Chem., January 17, 2003; 278(4): 2444 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xing, A. Nakamura, T. Korenaga, Z. Guo, J. Yao, X. Fu, T. Matsushita, K. Kogishi, M. Hosokawa, F. Kametani, et al. Induction of Protein Conformational Change in Mouse Senile Amyloidosis J. Biol. Chem., August 30, 2002; 277(36): 33164 - 33169. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Lachmann, D. R. Booth, S. E. Booth, A. Bybee, J. A. Gilbertson, J. D. Gillmore, M. B. Pepys, and P. N. Hawkins Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis N. Engl. J. Med., June 6, 2002; 346(23): 1786 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Frank and Y. L. Marcel Apolipoprotein A-I: structure;-function relationships J. Lipid Res., June 1, 2000; 41(6): 853 - 872. [Abstract] [Full Text] |
||||
![]() |
J.D. Gillmore, D.R. Booth, M. Rela, N.D. Heaton, V. Rahman, A.J. Stangou, M.B. Pepys, and P.N. Hawkins Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen {alpha}-chain variant in an English family QJM, May 1, 2000; 93(5): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Obici, V. Bellotti, P. Mangione, M. Stoppini, E. Arbustini, L. Verga, I. Zorzoli, E. Anesi, G. Zanotti, C. Campana, et al. The New Apolipoprotein A-I Variant Leu174 -> Ser Causes Hereditary Cardiac Amyloidosis, and the Amyloid Fibrils Are Constituted by the 93-Residue N-Terminal Polypeptide Am. J. Pathol., September 1, 1999; 155(3): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Walsh A Novel Amyloidogenic Variant of Apolipoprotein AI : Implications for a Conformational Change Leading to Cardiomyopathy Am. J. Pathol., January 1, 1999; 154(1): 11 - 14. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |